Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
Provided By PR Newswire
Last update: Aug 7, 2025
MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, today announced financial results for the second quarter ended June 30, 2025, and provided recent corporate progress.
Read more at prnewswire.com
